World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
45132
World Ranking
5148
National Ranking
2784

Matthew R. Weir publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matthew R. Weir sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 855 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matthew R. Weir D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew R. Weir sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Matthew R. Weir is affiliated with the University of Maryland, Baltimore in the United States. Their research mainly focuses on the field of Medicine, with extensive work in subfields such as Endocrinology, Diabetes and Metabolism, Nephrology, Surgery, Pulmonary and Respiratory Medicine, and Cardiology and Cardiovascular Medicine.

Their scholarly contributions cover numerous topics, including:

  • Diabetes Treatment and Management
  • Renal Transplantation Outcomes and Treatments
  • Chronic Kidney Disease and Diabetes
  • Potassium and Related Disorders
  • Blood Pressure and Hypertension Studies
  • Hormonal Regulation and Hypertension
  • Heart Failure Treatment and Management

Some of the main publication venues where their work frequently appears include:

  • Journal of the American Society of Nephrology
  • Journal of the American College of Cardiology
  • Kidney International
  • American Journal of Transplantation
  • American Journal of Nephrology

Matthew R. Weir has coauthored numerous papers with other researchers. Frequent collaborators in their work include George L. Bakris, Jonathan S. Bromberg, Jiang He, James P. Lash, and Panduranga S. Rao.

Representative recent papers authored or coauthored by them are:

  • The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2020), published in Kidney International
  • Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial (2020), published in Kidney International
  • Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022), published in European Heart Journal
  • Clinical Management of Hyperkalemia (2020), published in Mayo Clinic Proceedings
  • Abnormalities of Potassium in Heart Failure (2020), published in Journal of the American College of Cardiology

Best Publications

  • Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

    George L. Bakris;Matthew R. Weir

  • The evaluation of renal transplantation candidates: clinical practice guidelines.

    Bertram L. Kasiske;Charles B. Cangro;Sundaram Hariharan;Dondald E. Hricik

  • MYH9 is associated with nondiabetic end-stage renal disease in African Americans

    W H Linda Kao;Michael J Klag;Lucy A Meoni;David Reich;David Reich

  • The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease

    Lisa M. Einhorn;Min Zhan;Van Doren Hsu;Lori D. Walker

  • Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors

    Matthew R. Weir;George L. Bakris;David A. Bushinsky;Martha R. Mayo

  • Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

    George L. Bakris;Pantelis A. Sarafidis;Matthew R. Weir;Björn Dahlöf

  • Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

    George L. Bakris;Matthew R. Weir;Shahnaz Shanifar;Zhongxin Zhang

  • Cell-Free DNA and Active Rejection in Kidney Allografts

    Roy D Bloom;Jonathan S Bromberg;Emilio D Poggio;Suphamai Bunnapradist

  • The renin-angiotensin-aldosterone system: a specific target for hypertension management

    Matthew R Weir;Victor J Dzau

  • Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib

    Marvin A. Konstam;Matthew R. Weir;Alise Reicin;Deborah Shapiro

  • Clinical Course of Polyoma Virus Nephropathy in 67 Renal Transplant Patients

    Emilio Ramos;Cinthia B. Drachenberg;John C. Papadimitriou;Omar Hamze

  • Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the american heart association and the American college of cardiology foundation

    Krista L. Lentine;Salvatore P. Costa;Matthew R. Weir;John F. Robb

  • Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.

    George L. Bakris;Bertram Pitt;Matthew R. Weir;Mason W. Freeman

  • Microalbuminuria and Cardiovascular Disease

    Matthew R. Weir

  • Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

    Paul Muntner;Amanda Anderson;Jeanne Charleston;Zhen Chen

  • Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.

    Cinthia B. Drachenberg;David K. Klassen;Matthew R. Weir;Ann Wiland

  • Hypertension in CKD: Core Curriculum 2019.

    Elaine Ku;Benjamin J. Lee;Jenny Wei;Matthew R. Weir

  • Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trial

    Wouter B.A. Eijkelkamp;Zhongxin Zhang;Giuseppe Remuzzi;Hans Henrik Parving;Hans Henrik Parving

  • Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

    Krista L. Lentine;Salvatore P. Costa;Matthew R. Weir;John F. Robb

  • In the clinic: hypertension.

    Matthew R Weir

Frequent Co-Authors

George L. Bakris
George L. Bakris University of Chicago
Raymond R. Townsend
Raymond R. Townsend University of Pennsylvania
Bertram Pitt
Bertram Pitt University of Michigan–Ann Arbor
Mahboob Rahman
Mahboob Rahman Case Western Reserve University
Jiang He
Jiang He Tulane University
Lawrence J. Appel
Lawrence J. Appel Johns Hopkins University
Harold I. Feldman
Harold I. Feldman University of Pennsylvania
Chi-yuan Hsu
Chi-yuan Hsu University of California, San Francisco
John W. Kusek
John W. Kusek National Institutes of Health
Bertram L. Kasiske
Bertram L. Kasiske Hennepin County Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open up new career opportunities for those passionate about medicine but interested in different specialties or flexible study options. Online education has grown rapidly, making it easier to earn credible degrees or certifications remotely.

Those interested in administrative roles may consider pursuing a health care administration degree online. This provides a streamlined route to leadership positions within medical organizations. For individuals drawn to behind-the-scenes work, exploring top medical billing and coding financial aid programs can help offset costs as you train for these in-demand roles.

Nursing remains a popular and rewarding field. Many are now considering nursing school that don't require teas for more accessible entry points. Additionally, if you are an RN aiming to advance, rn to np programs online offer flexible, accelerated options to expand your qualifications.

By exploring these diverse online degrees and bridge programs, you can customize your healthcare career path and align your studies with your professional goals.

Best Scientists Citing Matthew R. Weir

Trending Scientists

Recently Published Articles